An approved diabetes drug may change the progression of Parkinson's disease rather than just treating symptoms while the disease worsens.

Feinstein Institute-led researchers used an Alzheimer’s drug to reduce inflammation in people with metabolic syndrome.

Targeting a cell process that promotes protein clumping could lead to new drugs for ALS.

A pair of experimental vaccines protected mouse fetuses from brain defects caused by Zika infection.

Researchers at Washington University have discovered a new way to shield fetuses from Zika using a common and inexpensive malaria drug.

A team led by Washington University in St. Louis has unraveled the structure of a protein that allows RSV to elude the immune system.

A new finding by scientists at NYU may prompt fresh ideas for reversing the buildup of plaque in arteries.

A University of Cambridge team used computer-designed antibodies to stop amyloid-beta plaques, a hallmark of Alzheimer's disease, from forming.

For the first time, Stanford University researchers have used a new type of whole-genome sequencing to diagnose a patient.

R&D